908 Devices Newsroom

Correction to 908 Devices Rating

Dow JonesNov 14 02:24

908 Devices Is Maintained at Buy by Stifel

Dow JonesNov 13 23:24

TD Cowen Maintains 908 Devices(MASS.US) With Buy Rating

Futu NewsNov 13 21:33

Stifel Maintains 908 Devices(MASS.US) With Buy Rating, Cuts Target Price to $6

Futu NewsNov 13 21:33

908 Devices Price Target Announced at $4.00/Share by Leerink Partners

Dow JonesNov 13 20:52

908 Devices Analyst Ratings

BenzingaNov 13 20:42

Leerink Partners Downgrades 908 Devices(MASS.US) to Hold Rating, Cuts Target Price to $4

Futu NewsNov 13 19:32

TD Cowen Initiates 908 Devices(MASS.US) With Buy Rating

Futu NewsNov 13 05:32

TD Cowen Reaffirms Their Buy Rating on 908 Devices (MASS)

TipRanksNov 13 05:29

908 Devices Is Maintained at Outperform by Leerink Partners

Dow JonesOct 17 23:00

908 Devices Analyst Ratings

BenzingaOct 17 22:52

Leerink Partners Maintains 908 Devices(MASS.US) With Buy Rating, Cuts Target Price to $12

Futu NewsOct 17 20:31

Buy Rating Affirmed for 908 Devices on Strong Market Position and Growth Prospects

TipRanksAug 9 17:58

TD Cowen Maintains 908 Devices(MASS.US) With Buy Rating

Futu NewsAug 7 00:31

Stephens & Co. : The 908 Devices (MASS.US) rating was confirmed and adjusted from an increase to an increase in holdings rating, with a target price of $14.00.

Zhitong FinanceMay 13 22:40

908 Devices Analyst Ratings

BenzingaMay 13 22:35

Stephens & Co. Reiterates Overweight on 908 Devices, Maintains $14 Price Target

BenzingaMay 13 22:35

Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), Aurinia Pharmaceuticals (AUPH) and 908 Devices (MASS)

TipRanksMay 2 14:30

Buy Rating Affirmed for 908 Devices Amidst PAT Growth and Solid Financial Outlook

TipRanksMar 7 12:21

Stifel Nicolaus Remains a Buy on 908 Devices (MASS)

TipRanksMar 6 20:41